the company’s diabetes franchise is seeing elevated growth and a substantial improvement in the immunohematology and quality control businesses. Bio-Rad recently launched the IH-500 next ...
the company’s diabetes franchise is seeing elevated growth and a substantial improvement in the immunohematology and quality control businesses. Bio-Rad recently launched the IH-500 next ...
Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...
--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE ... was primarily driven by an increased demand for our quality control and blood typing products. Currency neutral sales increased in EMEA ...